A Study Evaluating the Efficacy and Safety of Giredestrant Compared With Physician's Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (acelERA Breast Cancer)
Clinical trial NCT04576455 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04576455
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-27
- Primary completion
- 2022-02-18
- Enrollment
- 303
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.